跳至主要内容
临床试验/NCT03747510
NCT03747510已完成不适用

Prospective, Single-Center, Single Arm, Feasibility Study of the PAVmed CarpX Device for the Treatment of Carpal Tunnel Syndrome

PAVmed Inc.2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年1月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
PAVmed Inc.
入组人数
20
试验地点
2
主要终点
Device Safety defined as freedom from Serious Adverse Events probably or definitely related to the CarpX device resulting in significant morbidity.

研究概览

简要总结

To study the safety and feasibility of the CarpX device to divide and release the transverse carpal ligament in order to provide relief for Carpal Tunnel Syndrome (CTS).

详细描述

This is a prospective, single center, single arm, study of the CarpX device for treatment of carpel tunnel syndrome. Patients will be followed for up to 30 days post procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is > 18 years old
  • Patient is scheduled to undergo carpal tunnel release surgery
  • Patient has failed to respond to conservative treatment of CTS
  • CTS confirmed by strong clinical signs and positive Nerve Conduction Velocity (NCV) test
  • Patient, or authorized representative, signs a written Informed Consent form to participate in the study, prior to any study mandated procedures Patient is willing and able to complete follow-up requirements

排除标准

  • Patient has a prior or current musculoskeletal or neurologic condition that limits strength, motion, or sensation in the affected hand that is unrelated to carpal tunnel syndrome.
  • Patient with stiff wrist, suspected space occupying lesions or other anatomic abnormalities of the forearm, wrist or hand or other concerns related to patient anatomy such as small wrist and/or thin skin
  • Prior invasive treatment of the hand or wrist for disease processes such as De Quervain's syndrome, arthritic wrist etc. on the intended treatment side
  • Previous trauma/fracture or other anatomic abnormalities of the forearm, wrist or hand on the intended treatment side
  • Patient has an ipsilateral injury or other conditions affecting hand function
  • Patient has acute CTS resulting from an injury (e.g., fracture)
  • Patient has had previous CTR surgery on the affected hand
  • Patient has severe chronic median nerve neuropathy shown by the EMG and NCS that shows denervation of the thenar muscle
  • Active local or systemic infection
  • Known allergy to any device component
  • Known severe allergy to contrast reagent that cannot be managed with premedication
  • Any significant medical condition(s) that would place patient at excessive risk for surgery such as: known bleeding disorder including thrombocytopenia (platelet count < 80,000), thrombasthenia, hemophilia or Von Willebrand's disease, unstable cardiac disease, renal failure or uncontrolled diabetes
  • Patient has other medical, social or psychological problem that in the opinion of the investigator precludes them from fully participating
  • Women who are pregnant

结局指标

主要结局

Device Safety defined as freedom from Serious Adverse Events probably or definitely related to the CarpX device resulting in significant morbidity.

时间窗: Through 30-day

Freedom from Serious Adverse Events probably or definitely related to the CarpX device resulting in significant morbidity.

次要结局

  • Device Technical Success: defined as the ability of the CarpX Device to perform complete division of the transverse carpel ligament.(Through 30-day)

研究者

发起方
PAVmed Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验